Bioconversion of an anti-inflammatory drug meloxicam was
investigated by employing twelve bacterial strains
representing six genera. Among the bacterial cultures
screened, Bacillus subtilis MTCC 441 and
Pseudomonas putida NCIM 2782 could transform meloxicam
to 5-hydroxy methyl meloxicam. Whereas, other bacterial
cultures under study failed to transform meloxicam. The
progress of the transformation was confirmed by HPLC, and
based on LC-MS data and previous reports, the metabolite was
predicted to be 5-hydroxy methyl meloxicam.